Ozempic, Wegovy: India's cheap weight-loss drugs could reshape global obesity fight

With India’s semaglutide patent expiring on 20 March, about 50 branded generics are expected to enter the market.

By · · 1 min read
Ozempic, Wegovy: India's cheap weight-loss drugs could reshape global obesity fight

Source: www.bbc.com

With India’s semaglutide patent expiring on 20 March, about 50 branded generics are expected to enter the market.

Related Posts

Trending on ShareHub

Latest on ShareHub

Browse Topics

#artificial intelligence (31552) #data science (24017) #ai (16738) #generative ai (15034) #crypto (14987) #machine learning (14680) #bitcoin (14229) #featured (13550) #news & insights (13064) #crypto news (11082)

Around the Network